Yokoyama T - Search Results

1

High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatments.

Yokoyama T, Tsugawa M, Nagai A, Kumon H. Yokoyama T, et al. Acta Med Okayama. 2004 Jun;58(3):151-6. doi: 10.18926/AMO/32106. Acta Med Okayama. 2004. PMID: 15471437 Free article.

2

Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping.

Araki T, Yokoyama T, Kumon H. Araki T, et al. Among authors: yokoyama t. Acta Med Okayama. 2004 Feb;58(1):45-9. doi: 10.18926/AMO/32115. Acta Med Okayama. 2004. PMID: 15157011 Free article. Clinical Trial.

3

Long-term clinical outcomes of 420 consecutive prostate cancer patients in a single institute.

Edamura K, Saika T, Senoh T, Koizumi F, Manabe D, Ebara S, Kaku H, Yokoyama T, Abarzua F, Nagai A, Nasu Y, Tsushima T, Kumon H. Edamura K, et al. Among authors: yokoyama t. Acta Med Okayama. 2005 Oct;59(5):195-9. doi: 10.18926/AMO/31973. Acta Med Okayama. 2005. PMID: 16286958 Free article.

4

Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.

Kaku H, Saika T, Tsushima T, Nagai A, Yokoyama T, Abarzua F, Ebara S, Manabe D, Nasu Y, Kumon H. Kaku H, et al. Among authors: yokoyama t. Acta Med Okayama. 2006 Feb;60(1):43-9. doi: 10.18926/AMO/30759. Acta Med Okayama. 2006. PMID: 16508688 Free article. Clinical Trial.

5

Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.

Yokoyama T, Kumon H, Nasu Y, Takamoto H, Watanabe T. Yokoyama T, et al. Int J Urol. 2006 Jul;13(7):932-8. doi: 10.1111/j.1442-2042.2006.01443.x. Int J Urol. 2006. PMID: 16882058 Clinical Trial.

6

Natural course of lower urinary tract symptoms following discontinuation of alpha-1-adrenergic blockers in patients with benign prostatic hyperplasia.

Yokoyama T, Watanabe T, Saika T, Nasu Y, Kumon H, Miyaji Y, Nagai A. Yokoyama T, et al. Int J Urol. 2007 Jul;14(7):598-601. doi: 10.1111/j.1442-2042.2007.01784.x. Int J Urol. 2007. PMID: 17645601

7

Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.

Yokoyama T, Uematsu K, Watanabe T, Sasaki K, Kumon H, Nagai A; Okayama Urological Research Group. Yokoyama T, et al. Scand J Urol Nephrol. 2009;43(4):307-14. doi: 10.1080/00365590902836740. Scand J Urol Nephrol. 2009. PMID: 19396723 Clinical Trial.

8

Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxin.

Yokoyama T, Yamamoto Y, Suzuki T, Oguma K, Nagai A. Yokoyama T, et al. Acta Med Okayama. 2012;66(4):291-7. doi: 10.18926/AMO/48668. Acta Med Okayama. 2012. PMID: 22918201 Free article. Clinical Trial.

9

Botulinum toxin treatment of urethral and bladder dysfunction.

Yokoyama T, Kumon H, Smith CP, Somogyi GT, Chancellor MB. Yokoyama T, et al. Acta Med Okayama. 2002 Dec;56(6):271-7. doi: 10.18926/AMO/31693. Acta Med Okayama. 2002. PMID: 12685855 Free article. Review.

10

Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.

Watanabe T, Yokoyama T, Sasaki K, Nozaki K, Ozawa H, Kumon H. Watanabe T, et al. Among authors: yokoyama t. Int J Urol. 2004 Apr;11(4):200-5. doi: 10.1111/j.1442-2042.2003.00782.x. Int J Urol. 2004. PMID: 15028097 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,921 results

Search Page

Filters